利用“让更多艾滋病毒感染者和艾滋病患者参与”（GIPA）原则为奥斯汀过渡补助金地区的污名指数铺平道路（2024 年）.pdf

《利用“让更多艾滋病毒感染者和艾滋病患者参与”（GIPA）原则为奥斯汀过渡补助金地区的污名指数铺平道路（2024 年）.pdf》由会员分享，可在线阅读，更多相关《利用“让更多艾滋病毒感染者和艾滋病患者参与”（GIPA）原则为奥斯汀过渡补助金地区的污名指数铺平道路（2024 年）.pdf（10页珍藏版）》请在三个皮匠报告上搜索。

1、Paving the way for the Stigma Indexusing the Greater Involvement ofPeople Living with HIV and AIDS(GIPA)Principle in the AustinTransitional Grant Area,2024Michelle Osorio,MPHFlor Hernandez-Ayala,MD,MPH City of Austin,Austin Public HealthAbstract ID:USFTC251267September 15-17,2025What is stigma?Negat

2、ive attitude or idea about a mental,physical,or social feature of a person or group of people that implies social disapprovalStigma attitudes and perceptionsDiscrimination actions and behaviorsHIV stigma is negative attitudes and beliefs about people with HIVCan lead to discrimination,treating peopl

3、e with HIV differently than those without HIVAffects peoples health and wellbeing,and discourages people from engaging in HIV testing,prevention,and careViolates the human rights of people living with HIVSeptember 15-17,2025Case Study:PLHIV Stigma Index in Central TexasIn-person,interview-based asse

4、ssment to gather evidence on how stigma and discrimination impacts the lives of people living with HIVStandardized tool 100+countries have completed the study100,000+PLHIV have been interviewed Created by global networks of PLHIV with backing from UNAIDS and Johns Hopkins University Interviewers and

5、 participants(interviewees)are PLHIV Interview takes approximately 60-90 minutesParticipants will receive incentives of$100Research partner selected Cardea ServicesSeptember 15-17,2025Methods:Phase 1Number of PLHIV to be interviewedBastrop10Caldwell10Hays10Travis60Williamson12Phase 1 Total102Total s

6、ample size:336*divided into two phasesVenue-based&referral-based samplingPriority populations:gay men and other MSM;sex workers;transgender persons;people who use drugs;people experiencing homelessnessAll gender identities and sexual orientations may participate Main inclusion criteria:aware of HIV+